Contact system activation in patients with HAE and normal C1 inhibitor function

Area of Science:

• Immunology
• Genetics
• Hematology

Background:

• Hereditary angioedema (HAE) presents with C1 inhibitor deficiency or normal C1 inhibitor function.
• HAE with normal C1 inhibitor is linked to exaggerated kinin formation via contact phase activation.
• Factor XII gene mutations are found in some HAE families, but the cause is often elusive.

Purpose of the Study:

• To investigate the underlying mechanisms of hereditary angioedema with normal C1 inhibitor function.
• To identify genetic or molecular factors contributing to kinin system dysregulation in HAE.

Main Methods:

• Analysis of patient cohorts with HAE and normal C1 inhibitor.
• Genetic sequencing to identify mutations in relevant genes (e.g., Factor XII).
• Assessment of contact phase activation and kinin formation pathways.

Main Results:

• While Factor XII mutations explain some cases, the etiology remains unclear in the majority of families.
• Evidence suggests involvement of endothelium and mast cells in triggering the kinin-forming system.
• Angioedema episodes correlate with kinin accumulation and impaired kinin breakdown.

Conclusions:

• The pathogenesis of HAE with normal C1 inhibitor is complex and multifactorial.
• Further research is needed to elucidate the complete molecular basis and identify therapeutic targets.